The Latest
-
Norwegian Cruise further extends trip suspensions until September
-
5 things to watch on the ASX 200 on Wednesday
-
Oracle Sales Miss Estimates on Fewer Business Software Deals
-
Moderna (MRNA) Stock Is a Winner, But How Much Higher Can It Go?